Focus on Anticoagulation Care

Back to articles

Clopidogrel–Aspirin Therapy Holds Promise After Myocardial Infarction

KEY POINT

For secondary prevention in patients with unstable angina or who have had myocardial infarction (MI), dual therapy with clopidogrel (Plavix—Sanofi; Bristol-Myers Squibb) and aspirin may soon be the norm, if experimental results hold up in clinical testing.

SOURCES

Moshfegh K et al. Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy. J Am Coll Cardiol. 2000;36:699–705.